Sporobolomyces lactosus is a pink yeast-like fungus that’s not congeneric with different members of Sporobolomyces (Basidiomycota, Microbotryomycetes, Sporidiobolales). During our ongoing research of pink yeasts we decided that S. lactosus was most carefully associated to Pseudeurotium zonatum (Ascomycota, Leotiomycetes, Thelebolales).
A molecular phylogenetic evaluation utilizing sequences of the ITS area and the small and enormous subunit (SSU, LSU) rRNA genes, indicated that 4 isolates of S. lactosus, together with three ex-type isolates, had been positioned in Thelebolales with most assist. A brand new genus is proposed to accommodate S. lactosus, Inopinatum. This is the first pink yeast reported in Leotiomycetes.
Pelorhabdus rhamnosifermentans gen. nov., sp. nov., a strictly anaerobic rhamnose degrader from freshwater lake sediment
A rhamnose-degrading bacterium, pressure BoRhaAT, was remoted from profundal sediment of Lake Constance in agar dilution collection with l-rhamnose as substrate and with a background garden of Methanospirillum hungatei. The remoted pressure was a motile rod that stained Gram optimistic. Growth was noticed inside a pH vary of 4.0-7.5 and a temperature vary of 15-30°C. Fermentation merchandise of rhamnose or glucose had been acetate, propionate, ethanol, butyrate, and 1-propanol.
The G+C content material was 40.6% G+C. The dominant fatty acids are C16:1ω9c, i-C13:016:Zero and C17:1ω8c with 8-21% relative abundance. Polar lipids had been glycolipids, phosphatidylethanolamine, phosphoaminolipid and different lipids, of which phosphatidylethanolamine was most plentiful. The sequence of the 16S rRNA gene of the new isolate matches the sequence of its closest relative Anaerosporomusa subterranea to 92.4%.
A comparability of the genome with this pressure confirmed 60.2% genome-wide common amino acid identification (AAI), comparisons with different kind strains confirmed a most of 62.7% AAI. Thus, the definition of a brand new genus is justified for which we suggest the title Pelorhabdus. For pressure BoRhaAT, we suggest the title Pelorhabdus rhamnosifermentans gen. nov., sp. nov., with pressure BoRhaAT (DSM 111565T = JCM 39158T) as the kind pressure.
Metabonomic Study on the Plasma of High-Fat Diet-Induced Dyslipidemia Rats Treated with Ge Gen Qin Lian Decoction by Ultrahigh-Performance Liquid Chromatography-Mass Spectrometry
Gegen Qinlian decoction (GGQLD) has a particular impact on T2DM in clinic, and it has the impact of decreasing blood sugar, bettering insulin resistance, and bettering the blood lipid degree of rats with dyslipidemia, however the intervention mechanism of GGQLD on dyslipidemia has not been clarified. The modifications in endogenous metabolites in the plasma of high-fat diet-induced dyslipidemia rats handled with Ge Gen Qin Lian Decoction (GGQLD) had been studied to elucidate the therapeutic results and mechanism of motion of GGQLD in dyslipidemia.
Based on ultrahigh-performance liquid chromatography coupled with quadrupole-time-of-flight tandem mass spectrometry (UHPLC-Q-TOF-MS), the metabolic profiles of rat serum samples had been collected. The rat mannequin of dyslipidemia was induced by a 60% fat-fed high-fat weight loss program. After feeding the rats with a high-fat weight loss program for Four weeks, dyslipidemia appeared. After 5 weeks of GGQLD (14.85 g kg-1) administration, the metabonomics of rats’ plasma samples in the regular group, mannequin group, and administration group had been analyzed.
Mass profiler skilled (MPP), SIMCA-P 14.1, and Graphpad prism 6.Zero software program had been used mixed with METLIN organic database and human metabolite database HMDB to display and establish endogenous biomarkers. Metaboanalyst 4.Zero software program was utilized by combining with HMDB and KEGG databases; the enrichment and metabolic pathway of biomarkers had been analyzed to discover the metabolic mechanism of dyslipidemia rats induced by high-fat weight loss program and the intervention mechanism of Gegen Qinlian decoction.
After 5 weeks of administration of GGQLD, the ranges of serum TC and TG had been considerably decreased (P < 0.05, P < 0.01), whereas HDL-C and LDL-C weren’t considerably affected. After administration, the meals consumption of rats in the administration group decreased progressively, and the change pattern of physique weight progressively slowed down. The metabonomics of rat plasma samples outcomes confirmed that 23 potential biomarkers together with α-linolenic acid, arachidonic acid, and lysophosphatidylcholine had been considerably modified in optimistic ion mode.
Studies have proven that GGQLD has a major lipid-lowering impact on dyslipidemia rats induced by a high-fat weight loss program, and its preventive mechanism is said to tryptophan metabolism, fatty acid biosynthesis, α-linolenic acid metabolism, arachidonic acid, and glycerophosphatidyl metabolism pathway.
Clypifer cribrifer gen. nov., sp. nov. (Clypiferidae fam. nov., Pterocystida, Centroplasthelida), with notes on evolution of centrohelid siliceous coverings
A brand new household, genus and species of centrohelid heliozoans, Clypifer cribrifer gen. nov., sp. nov. (Clypiferidae fam. nov.), from the Gulf of Aqaba (Israel) was studied with mild and electron microscopy and SSU rRNA gene sequencing. Clypifer cribrifer has just one kind of scales, partially working up the sides of the axopodia. Plate scales [0.8-2.3 (av. 1.5)×0.6-1.8 (av. 1.2) μm] are flat, elliptical or round, fenestrated with holes of irregular form and have a marginal rim and a really quick axial rib. The cell diameter is 3.9-9.6 (av. 6.0) μm.
Molecular phylogenetic evaluation robustly locations C. cribrifer in the C4 clade for which the new household Clypiferidae is proposed right here. This place is confirmed with the quick sequences in the panacanthocystid elevated areas. The morphology of the new genus is analogous to the genus Raphidocystis.
Anti-Human MIG (CXCL9) |
|||
| MBS550702-02mg | MyBiosource | 0.2mg | 335 EUR |
Mouse anti Human CXCL9/MIG Monoclonal Antibody |
|||
| MBS2543500-006mL | MyBiosource | 0.06mL | 335 EUR |
Mouse anti Human CXCL9/MIG Monoclonal Antibody |
|||
| MBS2543500-012mL | MyBiosource | 0.12mL | 520 EUR |
Mouse anti Human CXCL9/MIG Monoclonal Antibody |
|||
| MBS2543500-02mL | MyBiosource | 0.2mL | 800 EUR |
Human MIG (CXCL9) |
|||
| MBS691716-0005mg | MyBiosource | 0.005mg | 300 EUR |
Human MIG (CXCL9) |
|||
| MBS691716-002mg | MyBiosource | 0.02mg | 450 EUR |
Human MIG (CXCL9) |
|||
| MBS691716-5x002mg | MyBiosource | 5x0.02mg | 1725 EUR |
MIG/CXCL9, Human |
|||
| HY-P7253 | MedChemExpress | 10ug | 321.6 EUR |
MIG, CXCL9, human |
|||
| RC312-20 | Bio Basic | 5ug | 125.26 EUR |
Human MIG Recombinant |
|||
| MBS553131-0005mg | MyBiosource | 0.005mg | 165 EUR |
Human MIG Recombinant |
|||
| MBS553131-002mg | MyBiosource | 0.02mg | 245 EUR |
anti- MIG antibody |
|||
| FNab05188 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against MIG |
|||
MIG, human recombinant |
|||
| 4240-1000 | Biovision | each | 5475.6 EUR |
MIG, human recombinant |
|||
| 4240-20 | Biovision | each | 346.8 EUR |
Anti-Human CXCL9/MIG Antibody |
|||
| MBS1569896-01mg | MyBiosource | 0.1mg | 375 EUR |
Anti-Human CXCL9/MIG Antibody |
|||
| MBS1569896-5x01mg | MyBiosource | 5x0.1mg | 1390 EUR |
Human MIG ELISA Kit |
|||
| GWB-SKR051 | GenWay Biotech | 96 Tests | Ask for price |
CXCL9 / MIG (74-103) (Human) |
|||
| 045-62 | PHOENIX PEPTIDE | 100 μg | 289.44 EUR |
CXCL9 / MIG (77-103) (Human) |
|||
| 045-63 | PHOENIX PEPTIDE | 100 μg | 257.04 EUR |
MIG (Human) ELISA Kit |
|||
| EKA51867-5x96T | Biomatik Corporation | 5x96T | Ask for price |
MIG (Human) ELISA Kit |
|||
| EKA51867-96T | Biomatik Corporation | 96T | 446.9 EUR |
Anti- Monokine Induced by IFN-gamma (MIG) Human Antibody |
|||
| GWB-B1A431 | GenWay Biotech | 0.1 mg | Ask for price |
Human CXCL9 (MIG) ELISA |
|||
| GWB-CXCL9E | GenWay Biotech | 96 well | Ask for price |
Human MIG (CXCL9), (Recombinant) |
|||
| 22060423-1 | Glycomatrix | 5 µg | 146.42 EUR |
Recombinant Human MIG (CXCL9) |
|||
| 7-02002 | CHI Scientific | 5µg | Ask for price |
Recombinant Human MIG (CXCL9) |
|||
| 7-02003 | CHI Scientific | 20µg | Ask for price |
Recombinant Human MIG (CXCL9) |
|||
| 7-02004 | CHI Scientific | 1mg | Ask for price |
Recombinant Human MIG (CXCL9) |
|||
| Z100665 | ABM | 20 µg | 235 EUR |
|
Description: MIG (CXCL9) protein belongs to the family of chemotactic cytokines known as chemokines. The synthesis of MIG is specifically induced in macrophages and in other cells by IFN-gamma.Human neutrophils produce mig in response to IFN-gamma in combination with either TNF-alpha or bacterial lipopolysaccharides and this response is blocked by IL-10 and IL-4. MIG is a chemoattractant for stimulated but not resting T cells, however it is not active on neutrophils or monocytes. |
|||
Recombinant Human MIG (CXCL9) |
|||
| Z100669 | ABM | 1.0 mg | 3900 EUR |
|
Description: MIG (CXCL9) protein belongs to the family of chemotactic cytokines known as chemokines. The synthesis of MIG is specifically induced in macrophages and in other cells by IFN-gamma.Human neutrophils produce mig in response to IFN-gamma in combination with either TNF-alpha or bacterial lipopolysaccharides and this response is blocked by IL-10 and IL-4. MIG is a chemoattractant for stimulated but not resting T cells, however it is not active on neutrophils or monocytes. |
|||
Recombinant Human MIG (CXCL9) |
|||
| HECXP-0901 | Cyagen | 5ug | Ask for price |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-0005mg | MyBiosource | 0.005mg | 240 EUR |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-002mg | MyBiosource | 0.02mg | 310 EUR |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-1mg | MyBiosource | 1mg | 2880 EUR |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-5x1mg | MyBiosource | 5x1mg | 12630 EUR |
Recombinant Human MIG (CXCL9) |
|||
| MBS4159693-002mg | MyBiosource | 0.02mg | 385 EUR |
Recombinant Human MIG (CXCL9) |
|||
| MBS4159693-1mg | MyBiosource | 1(mg) | 4600 EUR |
Recombinant Human MIG (CXCL9) |
|||
| MBS4159693-5x1mg | MyBiosource | 5x1mg | 20445 EUR |
Recombinant Human MIG/CXCL9 |
|||
| P1213-.005 | ApexBio | 5ug | 108.8 EUR |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human MIG/CXCL9 |
|||
| P1213-.1 | ApexBio | 100ug | 900.8 EUR |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human MIG/CXCL9 |
|||
| P1213-.5 | ApexBio | 500ug | 2020.8 EUR |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human CXCL9 (MIG) |
|||
| 6565 | Immunochemistry | 5 µg | 194 EUR |
MIG/CXCL9 (Recombinant) Human |
|||
| GWB-4B8A74 | GenWay Biotech | 0.02 mg | Ask for price |
CXCL9 / MIG, recombinant (Human) |
|||
| 033-15 | PHOENIX PEPTIDE | 10 μg | 390.96 EUR |
MIG Human Recombinant (CXCL9) |
|||
| rAP-0213 | Angio Proteomie | Inquiry | Ask for price |
Recombinant Human CXCL9 (MIG) |
|||
| MBS258295-0005mg | MyBiosource | 0.005mg | 305 EUR |
Recombinant Human CXCL9 (MIG) |
|||
| MBS258295-5x0005mg | MyBiosource | 5x0.005mg | 1210 EUR |
Human CXCL9/MIG Antibody Pair Set |
|||
| ABPR-ZB074 | Creative Diagnostics | 5 plates, 15 plates | Ask for price |
|
Description: Quantitative determination of Human CXCL9/MIG |
|||
Anti-Human MIG Rabbit Polyclonal Antibody |
|||
| TA328386 | Origene Technologies GmbH | 100 µg | Ask for price |
Mouse Monoclonal anti-human CXCL9 (MIG) |
|||
| hAP-0220 | Angio Proteomie | 100ug | 250 EUR |
Sheep Polyclonal anti-Human CXCL9 (MIG) |
|||
| hAP-5823 | Angio Proteomie | 50ug | 400 EUR |
InVivoMAb Anti-Human CXCL9/MIG (Iv0087) |
|||
| MBS1570117-01mg | MyBiosource | 0.1mg | 405 EUR |
InVivoMAb Anti-Human CXCL9/MIG (Iv0087) |
|||
| MBS1570117-5x01mg | MyBiosource | 5x0.1mg | 1520 EUR |
Human MIG/CXCL9 ELISA Kit |
|||
| E16HE0067 | EnoGene | 96T | 833.33 EUR |
Human MIG/CXCL9 ELISA KIT |
|||
| E42EH-272 | EnoGene | 96T/48T | Ask for price |
Human MIG/CXCL9 ELISA kit |
|||
| E22-HC114.48 | EnoGene | 48T | 295 EUR |
Human MIG/CXCL9 ELISA kit |
|||
| E22-HC114.96 | EnoGene | 96T | 395 EUR |
Human MIG/CXCL9 ELISA Kit |
|||
| RK00126 | Abclonal | 96 Tests | 625.2 EUR |
Human MIG/CXCL9 ELISA Kit |
|||
| RK04210 | Abclonal | 96T | 280 EUR |
Human MIG/CXCL9 ELISA Kit |
|||
| MBS8579179-48Tests | MyBiosource | 48Tests | 390 EUR |
Human MIG/CXCL9 ELISA Kit |
|||
| MBS8579179-5x96Tests | MyBiosource | 5x96Tests | 2275 EUR |
Human MIG/CXCL9 ELISA Kit |
|||
| MBS8579179-96Tests | MyBiosource | 96Tests | 495 EUR |
Human MIG / CXCL9 GENLISA ELISA |
|||
| KBH0049 | Krishgen | 1 x 96 wells | 286 EUR |
Human CXCL9/MIG ELISA Kit |
|||
| E28L0571 | EnoGene | 96T | 666.67 EUR |
Human CXCL9/MIG ELISA Kit |
|||
| MBS8123906-5x96Tests | MyBiosource | 5x96Tests | 2200 EUR |
Human CXCL9/MIG ELISA Kit |
|||
| MBS8123906-96Tests | MyBiosource | 96Tests | 480 EUR |
CXCL9 / MIG Human ELISA Kit |
|||
| MBS355396-5x96Tests | MyBiosource | 5x96Tests | 2680 EUR |
CXCL9 / MIG Human ELISA Kit |
|||
| MBS355396-96Tests | MyBiosource | 96Tests | 590 EUR |
MIG (Human) LumiAb ELISA Kit |
|||
| MBS9510805-1x96Wells | MyBiosource | 1x96Wells | 520 EUR |
MIG (Human) LumiAb ELISA Kit |
|||
| MBS9510805-5x96Wells | MyBiosource | 5x96Wells | 2395 EUR |
MIG (Human) Sandwich ELISA Kit |
|||
| OK-0150 | Assay Biotech | 1Kit | 217 EUR |
|
Description: MIG (Human) Colorimetric Sandwich ELISA Kit |
|||
MIG (Human) OmniKine ELISA Kit |
|||
| MBS9501877-1x96Wells | MyBiosource | 1x96Wells | 500 EUR |
MIG (Human) OmniKine ELISA Kit |
|||
| MBS9501877-5x96Wells | MyBiosource | 5x96Wells | 2300 EUR |
Human MIG (CXCL9) Recombinant Protein |
|||
| 100-072 | ReliaTech | 20 µg | 196.35 EUR |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
Human MIG (CXCL9) Recombinant Protein |
|||
| 100-072S | ReliaTech | 5 µg | 92.4 EUR |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
Recombinant Human MIG (CXCL9) Protein |
|||
| PROTQ07325-2 | BosterBio | 20ug | 380.4 EUR |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
Recombinant Human MIG/CXCL9 protein |
|||
| CD01286-5ug | Jiaxing Korain Biotech Ltd (BT Labs) | 5ug | 176 EUR |
|
Description: CXCL9 is a T-cell chemoattractant induced by IFN-γ belonging to the CXC chemokine family and it is also known as Monokine induced by gamma interferon (MIG). CXCL9 is closely related to two other CXC chemokines called CXCL10 and CXCL11 and they all elicit their chemotactic functions by interacting with the chemokine receptor CXCR3. CXCL9 is a cytokine that affects the growth, movement, or activation state of cells that participate in immune and inflammatory response and chemotactic for activated T-cells. Recombinant human CXCL9 contains 103 amino acids which is a single non-glycosylated polypeptide chain. The human CXCL9 shares 75 % and 67 % a.a. sequence identity with mouse and rat CXCL9. |
|||
Purified recombinant Human MIG protein |
|||
| MBS5308825-002mg | MyBiosource | 0.02mg | 435 EUR |
Purified recombinant Human MIG protein |
|||
| MBS5308825-5x002mg | MyBiosource | 5x0.02mg | 1905 EUR |
Armenian Hamster Anti-Mouse CXCL9 (MIG) Monoclonal antibody, clone MIG-2F5.5 |
|||
| CABT-L4535-1mg | Creative Diagnostics | 1 mg | 1076.4 EUR |
Armenian Hamster Anti-Mouse CXCL9 (MIG) Monoclonal antibody, clone MIG-2F5.5 |
|||
| CABT-L4535-5mg | Creative Diagnostics | 5 mg | 2886 EUR |
Armenian Hamster Anti-Mouse CXCL9 (MIG) Monoclonal antibody, clone MIG-2F5.5 |
|||
| CABT-L4535 | Creative Diagnostics | 1 mg; 5 mg | Ask for price |
|
Description: Armenian Hamster |
|||
Recombinant Human (E.Coli) MIG (CXCL9) |
|||
| RP-1035 | Alpha Diagnostics | 5 ug | 196.8 EUR |
Human MIG Recombinant Protein Lyophilized |
|||
| IHUMIGRLY5UG | Innovative research | each | 341 EUR |
|
Description: Human MIG Recombinant Protein Lyophilized |
|||
Human MIG Recombinant Protein Lyophilized |
|||
| MBS8432766-INQUIRE | MyBiosource | INQUIRE | Ask for price |
MIG Human Recombinant Protein (CXCL9) |
|||
| PROTQ07325-1 | BosterBio | Regular: 20ug | 380.4 EUR |
|
Description: MIG (monokine induced by gamma-interferon ) Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 103 amino acids and having a molecular mass of 11700 Dalton. The MIG is purified by proprietary chromatographic techniques. |
|||
MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-0005mg | MyBiosource | 0.005mg | 160 EUR |
MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-005mg | MyBiosource | 0.05mg | 290 EUR |
MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-1mg | MyBiosource | 1mg | 2200 EUR |
MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-5x1mg | MyBiosource | 5x1mg | 9755 EUR |
Anti-swine CXCL9 (MIG) PAb |
|||
| GWB-KI0055 | GenWay Biotech | 1 kit | Ask for price |
Rabbit anti MIG-7 Polyclonal Antibody |
|||
| TA354753 | Origene Technologies GmbH | 100 µg | Ask for price |
Rabbit anti MIG-7 Polyclonal Antibody |
|||
| MBS460433-01mg | MyBiosource | 0.1mg | 320 EUR |
Rabbit anti MIG-7 Polyclonal Antibody |
|||
| MBS460433-5x01mg | MyBiosource | 5x0.1mg | 1390 EUR |
Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-0005mg | MyBiosource | 0.005mg | 240 EUR |
Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-002mg | MyBiosource | 0.02mg | 310 EUR |
Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-1mg | MyBiosource | 1mg | 3815 EUR |
Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-5x1mg | MyBiosource | 5x1mg | 16840 EUR |
Recombinant Human MIG protein (C-6His) |
|||
| CD01287-10ug | Jiaxing Korain Biotech Ltd (BT Labs) | 10ug | 275 EUR |
|
Description: Recombinant Human C-X-C Motif Chemokine 9 is produced by our Mammalian expression system and the target gene encoding Thr23-Thr125 is expressed with a 6His tag at the C-terminus. |
|||
Recombinant Human MIG protein (C-6His) |
|||
| CD01287-50ug | Jiaxing Korain Biotech Ltd (BT Labs) | 50ug | 823 EUR |
|
Description: Recombinant Human C-X-C Motif Chemokine 9 is produced by our Mammalian expression system and the target gene encoding Thr23-Thr125 is expressed with a 6His tag at the C-terminus. |
|||
OKAG00051-96W - MIG ELISA Kit (Human) |
|||
| OKAG00051-96W | Aviva Systems Biology | 1plate:12x8-WellMicrostrips | 500 EUR |
OKRC00714-96W - MIG ELISA Kit (Human) |
|||
| OKRC00714-96W | Aviva Systems Biology | 96Wells | 525 EUR |
MIG Human Recombinant (CXCL9), His Tag |
|||
| rAP-0212 | Angio Proteomie | Inquiry | Ask for price |
CXCL9 / MIG, recombinant (Human) - ELISA Kit |
|||
| EK-033-15 | PHOENIX PEPTIDE | 96 wells | 603.72 EUR |
MIG antibody |
|||
| 10R-M169A | Fitzgerald | 500 ug | 240 EUR |
|
Description: Mouse monoclonal MIG antibody |
|||
MIG antibody |
|||
| 70R-MR007 | Fitzgerald | 50 ug | 400 EUR |
|
Description: Affinity purified Rabbit polyclonal MIG antibody |
|||
MIG antibody |
|||
| MBS532154-05mg | MyBiosource | 0.5mg | 370 EUR |
MIG antibody |
|||
| MBS532154-5x05mg | MyBiosource | 5x0.5mg | 1525 EUR |
MIG antibody |
|||
| MBS534409-005mg | MyBiosource | 0.05mg | 465 EUR |
MIG antibody |
|||
| MBS534409-01mg | MyBiosource | 0.1mg | 575 EUR |
MIG antibody |
|||
| MBS534409-5x01mg | MyBiosource | 5x0.1mg | 2430 EUR |
MIG Antibody |
|||
| C30114-100ul | Assay Biotech | 100μl | 217 EUR |
|
Description: MIG Rabbit Polyclonal Antibody |
|||
MIG Antibody |
|||
| C30114-50ul | Assay Biotech | 50μl | 143.5 EUR |
|
Description: MIG Rabbit Polyclonal Antibody |
|||
MIG/CXCL9 Matched ELISA Antibody Pair Set, Human |
|||
| MBS8118318-15Plates | MyBiosource | 15Plates | 600 EUR |
MIG/CXCL9 Matched ELISA Antibody Pair Set, Human |
|||
| MBS8118318-5Plates | MyBiosource | 5Plates | 345 EUR |
MIG/CXCL9 Matched ELISA Antibody Pair Set, Human |
|||
| MBS8118318-5x15Plates | MyBiosource | 5x15Plates | 2755 EUR |
Anti-CXCL9/MIG Antibody (aa23-125) |
|||
| MBS2401492-01mL | MyBiosource | 0.1mL | 595 EUR |
Anti-CXCL9/MIG Antibody (aa23-125) |
|||
| MBS2401492-5x01mL | MyBiosource | 5x0.1mL | 2500 EUR |
MIG |
|||
| chm-333 | ProSpec Tany | 5µg | 60 EUR |
|
Description: Recombinant Human MIG (CXCL9) |
|||
Human, MIG Human Recombinant Protein (CXCL9), His Tag |
|||
| PROTQ07325 | BosterBio | Regular: 20ug | 380.4 EUR |
|
Description: MIG Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 126 amino acids (23-125 a.a.) and having a molecular mass of 14kDa.;MIG is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
Nori® Human CXCL9/MIG ELISA Kit |
|||
| GR106310 | Genorise Scientific | 96-well | 461 EUR |
Recombinant Human MIG-C4 protein (C-6His) |
|||
| CD01285-10ug | Jiaxing Korain Biotech Ltd (BT Labs) | 10ug | 188 EUR |
|
Description: Recombinant Human Ly6/PLAUR Domain-Containing Protein 3 is produced by our Mammalian expression system and the target gene encoding Leu31-His286 is expressed with a 6His tag at the C-terminus. |
|||
Recombinant Human MIG-C4 protein (C-6His) |
|||
| CD01285-50ug | Jiaxing Korain Biotech Ltd (BT Labs) | 50ug | 517 EUR |
|
Description: Recombinant Human Ly6/PLAUR Domain-Containing Protein 3 is produced by our Mammalian expression system and the target gene encoding Leu31-His286 is expressed with a 6His tag at the C-terminus. |
|||
Biotinylated Anti-swine CXCL9 (MIG) PAb |
|||
| GWB-KI0059 | GenWay Biotech | 1 kit | Ask for price |
MIG ELISA Kit (Human) : 96 Wells (OKAG00051) |
|||
| OKAG00051 | Aviva Systems Biology | 96 Wells | 715.2 EUR |
|
Description: Description of target: This antimicrobial gene encodes a protein thought to be involved in T cell trafficking. The encoded protein binds to C-X-C motif chemokine 3 and is a chemoattractant for lymphocytes but not for neutrophils.;Species reactivity: Human;Application: ELISA;Assay info: Quantitative Colorimentric Sandwich ELISA;Sensitivity: 16 pg/mL |
|||
MIG (CXCL9) (NM_002416) Human Over-expression Lysate |
|||
| LS004283 | BosterBio | 100ug | 628 EUR |
|
Description: Transient overexpression lysate of chemokine (C-X-C motif) ligand 9 (CXCL9) |
|||
Recombinant Human CXCL9/MIG Protein, His Tag |
|||
| E40KMH960 | EnoGene | 20ug | 495 EUR |
CXCL9 / MIG, recombinant (Human) - I-125 Labeled |
|||
| T-033-15 | PHOENIX PEPTIDE | 10 μCi | 1145.88 EUR |
Mig-7 (MIG7) Antibody |
|||
| 20-abx211094 | Abbexa |
|
|
Mig-7 (MIG7) Antibody |
|||
| 20-abx339505 | Abbexa |
|
|
Mig-7 (MIG7) Antibody |
|||
| abx211094-100l | Abbexa | 100 µl | 350 EUR |
Mig-7 (MIG7) Antibody |
|||
| abx211094-50l | Abbexa | 50 µl | 250 EUR |
Mig-7 (MIG7) Antibody |
|||
| abx339505-100l | Abbexa | 100 µl | 350 EUR |
Mig-7 (MIG7) Antibody |
|||
| abx339505-50l | Abbexa | 50 µl | 250 EUR |
The chance that one other Clypifer species was described beneath a unique title in the centrohelid literature is mentioned. Clypiferidae symbolize the second lineage of Pterocystida, that are characterised by the presence of solely tangentially oriented plate scales of 1 kind. Possible methods of evolution of the centrohelid siliceous coverings are additionally mentioned.